Trial intelligence / Profile preview

Tamsulosin vs Phloroglucinol for JJ Stent Tolerance

NCT01061073Phase 3Completed

Sponsor
CHU de Poitiers
Start
Jan 2010
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tamsulosin in ureteral stent-related symptoms (USRS), sponsored by CHU de Poitiers. Started Jan 2010; status: completed.

02

Drugs

tamsulosin
03

Conditions

ureteral stent-related symptoms (USRS)

Beyond the preview

Go deeper on NCT01061073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01061073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call